Trial intelligence / Profile preview

Trimetazidine and Exercise in AF Rehabilitation after RFA

NCT04511520Completed

Sponsor
National Medical Research Center for Therapy and Preventive Medicine
Start
Jul 2013
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

Randomised, open-label trial of trimetazidine in Atrial fibrillation (AFib), sponsored by National Medical Research Center for Therapy and Preventive Medicine. Started Jul 2013; status: completed.

02

Drugs

trimetazidine
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT04511520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04511520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call